PHILADELPHIA, March 24, 2020 /PRNewswire/ -- Berger Montague is investigating securities fraud claims against Align Technology, Inc. ("Align" or the "Company") on behalf of all purchasers of Align common stock (NASDAQ: ALGN) between April 24, 2019 and July 24, 2019 (the "Class Period").
If you purchased Align shares, have information, would like to discuss this investigation, or have any questions concerning your rights or interests, please contact our attorneys Benjamin Galdston, Esq. at (619) 489-0300 or Andrew Abramowitz, Esq. at (215) 875-3015, or visit www.bergermontague.com/align-technology.
Align is a medical device company that designs and markets treatments for misaligned teeth. Its principal product is Invisalign, a line of clear dental aligners.
On July 24, 2019, after touting the potential for growth in the China market, the Company informed investors that shipments of Invisalign were lower than expected in the second quarter 2019, due, in large measure, to softness in China. This dramatic reversal shocked investors, and on this news, Align shares plummeted $74.26—27%—in a single day, falling from $275.16 per share to $200.90 per share.
If you purchased Align common stock during the Class Period, you may seek Court appointment as lead plaintiff to represent other injured investors in a class action. The lead plaintiff appointment deadline is May 1, 2020. You do not need to be a lead plaintiff to share in any potential class recovery.
Whistleblowers: Persons with non-public information regarding Align should consider their options to help Berger Montague's investigation.
Berger Montague, with offices in Philadelphia, Minneapolis, Washington, D.C., and San Diego, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for five decades and serves as lead counsel in courts throughout the United States.
Benjamin Galdston, Shareholder
Andrew Abramowitz, Senior Counsel
View original content to download multimedia:http://www.prnewswire.com/news-releases/algn-stock-berger-montague-investigates-securities-fraud-class-action-claims-against-align-technology-inc-nasdaq-algn-lead-plaintiff-deadline-is-may-1-2020-301029264.html
SOURCE Berger Montague